Canada Next Generation Sequencing (NGS) Market to 2032
Overview
The Canada Next Generation Sequencing (NGS) Market is expected to reach a 5,852.60 USD Billion by 2032 and is projected to grow at a CAGR of 24.20% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,733.41
Forecast, 2032 (USD Billion)
5,852.60
CAGR, 2024 - 2032
24.20%
Report Coverage
Canada
Canada Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
Canada Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,733.41 USD Billion
- Projected Market Size (2032): 5,852.60 USD Billion
- CAGR (2025-2032): 24.20%
Key Findings of Canada Next Generation Sequencing (NGS) Market
- The Canada Next Generation Sequencing (NGS) Market was valued at 5,852.60 USD Billion in 2024.
- The Canada Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Precision Medicine in Application Segment accounted for the largest share of the market with a revenue of 1,733.41 USD Billion
- The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 26.33% during the forecast period from 2024 to 2032.
Canada Next Generation Sequencing (NGS) Market Scope
Canada Next Generation Sequencing (NGS) Market Segmentation & Scope
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Canada Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,733.41 USD Billion |
| Market Value in 2032 | 5,852.60 USD Billion |
| CAGR (2025-2032) | 24.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,End User,Distribution Channel,Product & Service,Technology |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 1,733.41 USD Billion in 2024
- Key Country: Canada, leading in terms of revenue with value of 1,733.41 USD Billion in 2024.
Segments and Scope
-
Canada Next Generation Sequencing (NGS) Market to 2032, By Application
- Precision Medicine is the largest segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,733.41 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 24.20 % in forecast period 2025-2032.
-
Canada Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a revenue of 611.97 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 25.73 % in forecast period 2025-2032.
-
Canada Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,003.67 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 24.66 % in forecast period 2025-2032.
-
Canada Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a revenue of 814.30 USD Billion in the year 2024.
- Services is the Fastest growing segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 24.00 % in forecast period 2025-2032.
-
Canada Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,010.54 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in Canada Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 24.59 % in forecast period 2025-2032.
Canada Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
Canada Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
Canada Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,End User,Distribution Channel,Product & Service,Technology.
Canada Next Generation Sequencing (NGS) Market was valued at USD 1,733.41(Revenue in USD Billion) in 2020.
Canada Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The Precision Medicine segment is expected to dominate the Canada Next Generation Sequencing (NGS) Market, holding a largest market share of 1,733.41 USD Billion in 2024
Coming Soon....
Canada Next Generation Sequencing (NGS) Market Scope
Canada Next Generation Sequencing (NGS) Market Segmentation & Scope
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Frequently Asked Questions
The Canada Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,End User,Distribution Channel,Product & Service,Technology.
Canada Next Generation Sequencing (NGS) Market was valued at USD 1,733.41(Revenue in USD Billion) in 2020.
Canada Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Next Generation Sequencing (NGS) Market for final year is USD 5,852.60 (USD Billion).
Canada Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Canada Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,End User,Distribution Channel,Product & Service,Technology.
Canada Next Generation Sequencing (NGS) Market was valued at USD 1,733.41(Revenue in USD Billion) in 2020.
Canada Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 24.20% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Next Generation Sequencing (NGS) Market for final year is USD 5,852.60 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.